SCHEMBL6290496

SCHEMBL6290496

Fc1cccc(Oc2ccc(Oc3cccc(F)c3)cc2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.54
▸ SMN1; SMN2 Q16637 2/20 0.54
▸ MEN1 O00255 1/20 0.54
▸ MITF O75030 1/20 0.54
▸ GAA P10253 1/20 0.54
▸ MAPT P10636 1/20 0.54
▸ GFER P55789 1/20 0.54
▸ KMT2A Q03164 1/20 0.54
▸ NLRP1 Q9C000 1/20 0.54
▸ NOD2 Q9HC29 1/20 0.54
▸ MMP14 P50281 2/20 0.51
▸ MMP2 P08253 1/20 0.51
▸ MMP3 P08254 1/20 0.51
▸ MMP9 P14780 1/20 0.51
▸ PGR P06401 1/20 0.49
▸ KCNH2 Q12809 1/20 0.48
▸ SCN3A Q9NY46 1/20 0.48
▸ MAOB P27338 1/20 0.46
▸ LTA4H P09960 1/20 0.46
▸ TSHR P16473 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6289347 1.00 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2MEN1MITFGAA
SCHEMBL6293128 0.98 SMN1; SMN2 (0.58) ALDH1A1SMN1; SMN2MEN1MITFGAA
SCHEMBL6290467 0.98 SMN1; SMN2 (0.58) ALDH1A1SMN1; SMN2MEN1MITFGAA
SCHEMBL6289422 0.98 SMN1; SMN2 (0.58) ALDH1A1SMN1; SMN2MEN1MITFGAA
SCHEMBL6290729 0.98 SMN1; SMN2 (0.58) ALDH1A1SMN1; SMN2MEN1MITFGAA
SCHEMBL6290588 0.98 SMN1; SMN2 (0.58) ALDH1A1SMN1; SMN2MEN1MITFGAA
SCHEMBL6290322 0.98 SMN1; SMN2 (0.58) ALDH1A1SMN1; SMN2MEN1MITFGAA
SCHEMBL7940811 0.95 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2MEN1MITFGAA
SCHEMBL7938427 0.95 MAPT (0.46) ALDH1A1SMN1; SMN2MEN1MITFGAA
SCHEMBL8416223 0.93 LTA4H (0.57) ALDH1A1SMN1; SMN2MEN1MITFGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6933411-B2 Aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2005-08-23 — — US disclosed
US-6737503-B2 LOW TEMPERATURE ADHESIVE BONDING MITSUI CHEMICALS, INC. (JP) 2004-05-18 — — US disclosed
US-20040082754-A1 Novel aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2004-04-29 — — US disclosed
US-20030092870-A1 Novel aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2003-05-15 — — US disclosed
EP-1288191-A2 Novel aromatic diamine and polyimide thereof Mitsui Chemicals, Inc. (JP) 2003-03-05 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030092870-A1 Novel aromatic diamine and polyimide thereof DDT, AOC1, H1-4 ALDH1A1 902/4885SMN1; SMN2 2287/4885MEN1 2058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback